文献速递药物不良反应与药物警戒

主动区域药物警戒系统与国家自发报告在收集超说明书用药安全数据中的比较:法国巴氯芬治疗酒精依赖的示例

Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.
PubMed 文献 · Drug Saf · 2017-01-01

该研究利用法国药物警戒数据库,比较主动区域系统CAMTEA与国家自发报告系统在收集巴氯芬超说明书用药相关不良反应上的表现。共识别428份报告(1043例不良反应),其中CAMTEA来源占51.64%。严重报告中最常见的不良反应为意识模糊(17.3%)、癫痫发作(11.5%)和嗜睡/镇静(11.5%)等,且多数类型在两种报告系统间的标准化差异小于0.2,提示主动系统能收集大量与自发报告性质相似的安全性数据。

要点

  • CAMTEA主动系统贡献了51.64%的巴氯芬超说明书用药不良反应报告。
  • 严重报告前十位不良反应包括意识模糊、癫痫发作和嗜睡/镇静等。
  • 多数不良反应类型在主动与自发报告系统间的标准化差异小于0.2。

核心结论

  • 主动区域药物警戒系统能针对特定超说明书用药实践收集大量安全性数据。
  • 所收集的不良反应谱与国家自发报告系统相似。

研究设计与样本

  • 基于法国药物警戒数据库(FPVD)2012-2013年数据的比较研究。
  • 提取与巴氯芬超说明书用药相关的报告,比较CAMTEA主动系统与自发报告。

主要发现

  • 共识别428份巴氯芬报告,涉及1043例不良反应,其中221份(51.64%)来自CAMTEA。
  • 严重报告中最常见的不良反应为意识模糊(17.3%)、癫痫发作(11.5%)、嗜睡/镇静(11.5%)、激越(10.9%)、昏迷(9.6%)。
  • 严重报告前十位不良反应中有六种、非严重报告前十位中有八种的标准化差异小于0.2。

临床怎么用

  • 对于超说明书用药的安全监测,可考虑建立主动区域药物警戒系统以补充自发报告的不足。
  • 主动系统收集的不良反应谱与自发报告相似,可作为安全性数据的重要来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Off-label prescribing (OLP) may raise serious safety concerns that traditional spontaneous reporting of adverse drug reactions (ADRs) may not identify in a timely manner. In France, the 'Multidisciplinary Consultation Service for Off-Label Prescribing in Addiction Medicine' (CAMTEA) is a proactive regional system established to identify ADRs associated with the OLP of baclofen for alcohol dependence. OBJECTIVE: The aim was to demonstrate, using the French pharmacovigilance database (FPVD), that CAMTEA allowed for the reporting of a substantial amount of ADRs, comparable in nature to those provided via spontaneous reporting. METHOD: The 2012-2013 FPVD notifications associated with baclofen OLP were extracted. The ten most frequent types of ADRs among 'serious' and 'non-serious' reports were listed. The frequency of each type of ADR was compared between CAMTEA and spontaneous reporting, and the magnitudes of the differences were assessed using standardized differences. RESULTS: A total of 428 baclofen reports (1043 ADRs) were identified, among which 221 (51.64%) originated from CAMTEA. The ten most frequent ADRs in 'serious' reports were (1) confusion (17.3%), (2) seizures (11.5%), (3) drowsiness/sedation (11.5%), (4) agitation (10.9%), (5) coma (9.6%), (6) hallucinations (7.7%), (7) falls (7.1%), (8) behavioral disorders (5.8%), (9) withdrawal syndrome (5.1%), and (10) space-time disorientation (5.1%). A standardized difference of <0.2 was identified for six out of the ten most frequent 'serious' ADRs, and eight of the ten 'non-serious' ADRs. CONCLUSION: A proactive regional pharmacovigilance system could collect a substantial amount of safety data on a specific OLP practice. The profile of the ADRs collected was similar to that seen in the nationwide spontaneous reporting system.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Auffret M, Labreuche J, Duhamel A, et al. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France. Drug Saf. 2017. PMID: 27988884. doi:10.1007/s40264-016-0489-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。